Weiyuan Biotechnology Overview
- Year Founded
-
2023
- Status
-
Private
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$13.9M
- Investors
-
7
Weiyuan Biotechnology General Information
Description
Provider of enzyme evolution and high-throughput screening technologies intended to enhance the production of chiral compounds, active natural product extraction and rapid construction of recombinant cell factories. The company's biotechnologies are based on the intelligent evolution of enzymes and high-throughput screening of strains, as well as precision analysis and intelligent prediction techniques, providing businesses in the biotechnology sector with improved production of chiral compounds, increased efficiency in the extraction of active natural products and faster construction of recombinant cell factories.
Contact Information
Website
www.wybio.ccCorporate Office
- Room 401, Building 7, Number 611, Dongguan Road
- Puyan Street, Binjiang District
- Hangzhou, Zhejiang 310000
- China
Corporate Office
- Room 401, Building 7, Number 611, Dongguan Road
- Puyan Street, Binjiang District
- Hangzhou, Zhejiang 310000
- China
Weiyuan Biotechnology Timeline
Weiyuan Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC | 19-Aug-2025 | $13.9M | Completed | Generating Revenue | ||
| 3. Early Stage VC | 27-Apr-2025 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 27-Jun-2024 | $1.42M | Completed | Generating Revenue | ||
| 1. Seed Round | 05-Jun-2023 | $1.42M | $1.42M | Completed | Startup |
Weiyuan Biotechnology Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Dalton Venture | Venture Capital | Minority | ||
| Roton Capital | Venture Capital | Minority | ||
| Hangzhou Oufang Venture Capital Management | Growth/Expansion | Minority | ||
| Silicon Valley Real Stone Asset Management | Asset Manager | Minority | ||
| Xinghua Dingli Capital | Venture Capital | Minority |
Weiyuan Biotechnology FAQs
-
When was Weiyuan Biotechnology founded?
Weiyuan Biotechnology was founded in 2023.
-
Where is Weiyuan Biotechnology headquartered?
Weiyuan Biotechnology is headquartered in Hangzhou, China.
-
What industry is Weiyuan Biotechnology in?
Weiyuan Biotechnology’s primary industry is Biotechnology.
-
Is Weiyuan Biotechnology a private or public company?
Weiyuan Biotechnology is a Private company.
-
What is Weiyuan Biotechnology’s current revenue?
The current revenue for Weiyuan Biotechnology is .
-
How much funding has Weiyuan Biotechnology raised over time?
Weiyuan Biotechnology has raised $15.4M.
-
Who are Weiyuan Biotechnology’s investors?
Dalton Venture, Roton Capital, Hangzhou Oufang Venture Capital Management, Silicon Valley Real Stone Asset Management, and Xinghua Dingli Capital are 5 of 7 investors who have invested in Weiyuan Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process